A detailed history of Comprehensive Financial Consultants Institutional, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Comprehensive Financial Consultants Institutional, Inc. holds 36,985 shares of MRK stock, worth $3.67 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares
36,985
Previous 35,932 2.93%
Holding current value
$3.67 Million
Previous $4.45 Million 5.58%
% of portfolio
1.62%
Previous 1.83%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$111.15 - $128.97 $117,040 - $135,805
1,053 Added 2.93%
36,985 $4.2 Million
Q2 2024

Jul 17, 2024

BUY
$123.8 - $132.96 $218,754 - $234,940
1,767 Added 5.17%
35,932 $4.45 Million
Q1 2024

May 02, 2024

SELL
$113.24 - $131.95 $226 - $263
-2 Reduced 0.01%
34,165 $4.51 Million
Q4 2023

Jan 24, 2024

BUY
$100.18 - $109.02 $122,520 - $133,331
1,223 Added 3.71%
34,167 $3.72 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $177,074 - $196,647
1,720 Added 5.51%
32,944 $3.39 Million
Q2 2023

Jul 24, 2023

SELL
$108.61 - $118.38 $84,933 - $92,573
-782 Reduced 2.44%
31,224 $3.6 Million
Q1 2023

Apr 19, 2023

BUY
$102.94 - $114.86 $120,645 - $134,615
1,172 Added 3.8%
32,006 $3.41 Million
Q4 2022

Jan 30, 2023

SELL
$87.44 - $112.11 $20,548 - $26,345
-235 Reduced 0.76%
30,834 $3.42 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $132,712 - $149,087
1,570 Added 5.32%
31,069 $2.92 Million
Q2 2022

Aug 09, 2022

SELL
$83.49 - $94.64 $14,109 - $15,994
-169 Reduced 0.57%
29,499 $2.76 Million
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $112,029 - $125,577
1,524 Added 5.42%
29,668 $2.62 Million
Q4 2021

Mar 10, 2022

BUY
$72.28 - $90.54 $2.03 Million - $2.55 Million
28,144 New
28,144 $2.15 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Comprehensive Financial Consultants Institutional, Inc. Portfolio

Follow Comprehensive Financial Consultants Institutional, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.